Nifedipine [orch, phsu]
Dose [qnco]
Mortality [qnco]
coronary heart disease [dsyn]
Purpose [ftcn]
Study [mnob]
Dose [qnco]
Nifedipine [orch, phsu]
Dihydropyridine [orch, phsu]
calcium antagonist [phsu]
Increased [qnco]
Mortality [qnco]
Seen [qlco]
randomized [resa]
secondary [neop]
prevention trials [resa]
Mechanisms [ftcn]
Adverse Effect [fndg]
Methods [inpr]
Restricted [ftcn]
Dose [qnco]
Response [orga]
Meta-Analysis [inpr]
randomized [resa]
secondary [neop]
prevention trials [resa]
Nifedipine [orch, phsu]
Mortality [qnco]
Available [ftcn]
Trial [resa]
calcium antagonist [phsu]
Formulation [resa]
reviewed [inpr]
Information [idcn]
Mechanisms [ftcn]
Action [ftcn]
Mortality [qnco]
Nifedipine [orch, phsu]
Adverse Effect [fndg]
Mortality [qnco]
Risk Ratio [qnco]
summary [inpr]
Estimate [qnco]
fail [ftcn]
Draw [inpr]
Attention [menp]
dose-response relationship [biof]
Daily Dose [qnco]
mg% [qnco]
Risk Ratios [qnco]
Mortality [qnco]
form test [mnob]
Dose [qnco]
Response [orga]
High dose [qnco]
Nifedipine [orch, phsu]
Increased [qnco]
Mortality [qnco]
P NOS [aapp, imft]
Mechanism [ftcn]
Adverse Effect [fndg]
Known [qlco]
Several [qnco]
Explanations [inpr]
Including [ftcn]
Established [qlco]
Negative [qlco]
Marked [qlco]
Hypotension [fndg]
Recently [tmco]
Reported [inpr]
effects [qlco]
Attribute [idcn]
actions [ftcn]
calcium antagonist [phsu]
Possibly [qlco]
effects [qlco]
Conclusions [idcn]
Patients [podg]
Coronary Disease [dsyn]
short [qlco]
Nifedipine [orch, phsu]
Moderate [qlco]
High dose [qnco]
Mortality [qnco]
calcium antagonist [phsu]
adverse effects [ftcn]
Dihydropyridine [orch, phsu]
Safety [hcpp]
Lacking [qlco]
calcium antagonist [phsu]
